Different variables have been employed in classifying patients who are at low, intermediate, and high risk for tumor recurrence after local therapy; these include standard pre and postoperative clinical and pathological variables including tumor stage, serum PSA levels, and Gleason scores [7–9]. The gene discussed is KLK3; the disease is neoplasm.